The Cancer Institute is dedicated to changing the reality of one of the leading causes of death worldwide. Any Mount Sinai researcher or clinician whose work touches cancer in any way will be connected to the Institute. Investigators – full-time members as well as members of a larger matrix organization – will work together to integrate Mount Sinai’s expanding research capacity in developmental and molecular biology, stem cells, cancer biology, and pharmacology with its current clinical programs, including those in liver, breast, prostate, head and neck, and hematological malignancies.